Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 11:26 am Purchase | 2024-11-29 | 13G | Annexon, Inc. ANNX | FMR LLC | 13,930,972 13.100% | 5,369,023 (+62.71%) | Filing History |
| 2024-11-14 7:21 pm Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | BB Biotech AG | 5,157,290 4.900% | 475,000 (+10.14%) | Filing History |
| 2024-11-14 6:46 pm Sale | 2024-09-30 | 13G | Annexon, Inc. ANNX | Logos Global Management LP | 2,900,000 2.700% | -4,044,444 (-58.24%) | Filing History |
| 2024-11-14 5:30 pm Sale | 2024-09-30 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 5,974,716 5.500% | -2,087,003 (-25.89%) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 9,027,778 8.400% | 2,027,778 (+28.97%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Annexon, Inc. ANNX | T. Rowe Price Associates, Inc. | 1,034,652 1.000% | -1,842,015 (-64.03%) | Filing History |
| 2024-11-12 09:50 am Sale | 2024-11-08 | 13G | Annexon, Inc. ANNX | FMR LLC | 8,561,949 8.103% | -1,123,452 (-11.60%) | Filing History |
| 2024-11-12 09:38 am Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | Adage Capital Management L.P. | 3,485,931 3.280% | 3,485,931 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Annexon, Inc. ANNX | BlackRock Inc. BLK | 7,647,714 7.200% | 0 (Unchanged) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | BlackRock Inc. BLK | 7,647,714 7.200% | 6,686,671 (+695.77%) | Filing History |
| 2024-04-22 8:35 pm Purchase | 2024-04-17 | 13G | Annexon, Inc. ANNX | BB Biotech AG | 4,682,290 5.200% | 4,682,290 (New Position) | Filing History |
| 2024-02-14 8:46 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | Venrock Healthcare Capital Partners II L.P. | 968,679 1.200% | -3,960,321 (-80.35%) | Filing History |
| 2024-02-14 4:58 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | CITADEL ADVISORS LLC | 1,069,087 1.400% | -1,431,220 (-57.24%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group LLC | 8,083,776 9.900% | 3,186,201 (+65.06%) | Filing History |
| 2024-02-14 3:45 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | Fairmount Funds Management LLC | 322,893 0.400% | -3,358,563 (-91.23%) | Filing History |
| 2024-02-14 12:43 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -3,626,508 (Position Closed) | Filing History |
| 2024-02-14 10:26 am Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% | 3,219,306 (+85.15%) | Filing History |
| 2024-02-13 7:23 pm Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | Logos Global Management LP | 6,944,444 8.300% | 3,844,444 (+124.01%) | Filing History |
| 2024-02-13 6:57 pm Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund L.P. | 8,061,719 11.000% | 5,121,092 (+174.15%) | Filing History |
| 2024-02-12 4:24 pm Purchase | 2024-02-02 | 13G | Annexon, Inc. ANNX | Point72 Asset Management, L.P. | 4,868,603 6.200% | 4,868,603 (New Position) | Filing History |